Stay updated on ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial.
Sign up to get notified when there's something new on the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page.

Latest updates to the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page
- Check2 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0, while the study record remains inaccessible behind a 403 error.SummaryDifference0.2%

- Check9 days agoChange DetectedA notice was added announcing that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434.SummaryDifference1%

- Check16 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2. The page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check44 days agoChange DetectedAccess to the study page now shows a 403 Forbidden error, replacing the study content with a standard error page header and footer; the visible content indicates the page is blocked rather than displaying the record details.SummaryDifference18%

- Check65 days agoChange DetectedA new Revision: v3.6.6 was added and the previous Revision: v3.6.5 was removed, reflecting an update to the page's version metadata.SummaryDifference0.1%

Stay in the know with updates to ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page.